Ulrike Setinek

Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications

Walter Berger, Ulrike Setinek, Peter Hollaus et al. · Journal of Cancer Research and Clinical Oncology · 2005 · 139 citations · Full text

Prognostic Biomarkers, Health Sciences, Lung Resistance Protein +9

Down-Regulation of Sprouty2 in Non–Small Cell Lung Cancer Contributes to Tumor Malignancy via Extracellular Signal-Regulated Kinase Pathway-Dependent and -Independent Mechanisms

Hedwig Sutterlüty, Christoph‐Erik Mayer, Ulrike Setinek et al. · Molecular Cancer Research · 2007 · 114 citations · Full text

Evidence for a role of FGF-2 and FGF receptors in the proliferation of non-small cell lung cancer cells

Walter Berger, Ulrike Setinek, Thomas Mohr et al. · International Journal of Cancer · 1999 · 114 citations · Full text

FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities

Sigrid Allerstorfer, Gudrun Sonvilla, Hendrik Fischer et al. · Oncogene · 2008 · 105 citations · Full text

Oncogenic Factor, Human Glioblastoma Multiforme, Medicine +9

Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition

Hendrik Fischer, Ninon Taylor, Sigrid Allerstorfer et al. · Molecular Cancer Therapeutics · 2008 · 102 citations · Full text